Exhibit 107
Calculation of Filing Fee Tables
Schedule TO
(Form Type)
Theravance Biopharma, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Transaction Valuation
| Transaction Valuation | Fee rate | Amount of Filing Fee | ||||||||||
| Fees to Be Paid | $ | 230,000,000 | * | 0.00927 | % | $ | 21,321 | ** | ||||
| Fees Previously Paid | - | $ | 0 | |||||||||
| Total Transaction Valuation | $ | 230,000,000 | * | |||||||||
| Total Fees Due for Filing | $ | 21,321 | ||||||||||
| Total Fees Previously Paid | $ | - | ||||||||||
| Total Fee Offsets | $ | - | ||||||||||
| Net Fee Due | $ | 21,321 | ||||||||||
| * | Calculated solely for purposes of determining the amount of the filing fee. The transaction valuation assumes that all $230,000,000 aggregate principal amount of the issuer’s 3.25% Convertible Senior Notes due 2023 are purchased at the tender offer price of $1,000 per $1,000 principal amount of such Convertible Notes. |
| ** | The amount of the filing fee was calculated in accordance with Rule 0-11 of the Securities Exchange Act of 1934, as amended, and equals $92.70 for each $1,000,000 of the value of the transaction. |